Context Therapeutics's total assets for Q2 2026 were $46.13M, a decrease of -21.62% from the previous quarter. DE:6K9 total liabilities were $7.96M for the fiscal quarter, a 19.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.